Treating Nonalcoholic Steatohepatitis With Pioglitazone
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00062764|
Recruitment Status : Completed
First Posted : June 13, 2003
Results First Posted : April 5, 2011
Last Update Posted : December 19, 2012
|Study Design||Intervention Model: Single Group Assignment; Masking: None (Open Label); Primary Purpose: Treatment|
Drug: Actos (Pioglitazone)
|Recruitment Details||Between March 2001 and April 2002, 25 patients suspected of having NASH were evaluated, and 18 were enrolled in the study after screening.|
A major limitation of this study was the lack of a concurrently followed control group.
Another important shortcoming of this study was that patients were treated for 48 weeks only.